The safety assessment of the Authority on the primary product AM 01, adopted on 26 November 2009 [EFSA Journal 2010; 8(1):1396.] and on 2 February 2012 [EFSA Journal 2012; 10(2):2580.], concludes that the data provided by the applicant is sufficient to eliminate the concerns over its genotoxicity. However, the uses and use levels as originally proposed by the applicant provide an insufficient margin of safety. The uses and the use levels have been revised to take into account this opinion. The primary product AM 01 should therefore be authorised subject to specific conditions of use.
Recital 14, Commission Implementing Regulation (EU) No 1321/2013 of 10 December 2013 establishing th…
In forcesince 10 Dec 2013